Department of Neurology, Jagiellonian University Medical College, Krakow, Poland.
Department of Neurology, University Hospital, Krakow, Poland.
Neurol Neurochir Pol. 2024;58(2):185-192. doi: 10.5603/pjnns.98219. Epub 2024 Feb 7.
This study aimed to identify predictors of 90-day good functional outcome (GFO) in patients with acute ischaemic stroke (AIS) who were treated with mechanical thrombectomy but did not achieve a delayed neurological improvement (DNI).
In-hospital neurological improvement in patients with AIS is consistently associated with long- -term GFO. Patients who experience neither early nor delayed neurological improvement can still achieve long-term GFO, but predictors of such an outcome have not been studied.
This single-centre retrospective study involved 307 patients with anterior circulation AIS treated with mechanical thrombectomy. Multiple clinical, biochemical, radiological, and treatment-related variables were collected and analysed. DNI on day 7 was defined as at least a 10-point reduction in the National Institutes of Health Stroke Scale (NIHSS) score or NIHSS score < 2. GFO on day 90 was defined as a modified Rankin Scale (mRS) score ≤ 2. We compared the characteristics of patients with and without DNI, with special attention paid to patients who achieved 90-GFO despite a lack of DNI. Multivariate analyses were then performed to establish independent predictors of 90-day GFO among patients without DNI.
DNI occurred in 150 out of 307 patients (48.7%) and significantly increased the odds for 90-day GFO (odds ratio [OR]: 13.99; p < 0.001). Among patients without DNI, 41.4% achieved 90-day GFO. Younger age (OR: 0.96; 95% confidence interval [CI]: 0.93-0.99; p = 0.008), lower baseline NIHSS score (OR: 0.80; 95% CI: 0.73-0.89; p < 0.001), treatment with intravenous thrombolysis (OR: 3.06; 95% CI: 1.25-7.49; p = 0.014), lack of an undetermined aetiology (OR: 0.40; 95% CI: 0.16-0.998; p = 0.050), lack of pneumonia (OR: 0.08; 95% CI: 0.02-0.31; p < 0.001), and higher haemoglobin concentration on admission (OR: 1.31; 95% CI: 1.04-1.69; p = 0.024) were identified as predictors of 90-day GFO in this subgroup.
Almost half of patients with AIS in anterior circulation treated with mechanical thrombectomy experience DNI, which is a good predictor of 90-day GFO. Furthermore, 40% of patients without DNI achieve 90-day GFO which can be independently predicted by younger age, lower baseline NIHSS score, treatment with intravenous thrombolysis, higher haemoglobin concentration on admission, lack of undetermined ischaemic stroke aetiology, and lack of pneumonia.
本研究旨在确定接受机械取栓治疗但未出现延迟神经功能改善(DNI)的急性缺血性卒中(AIS)患者 90 天良好功能结局(GFO)的预测因素。
AIS 患者住院期间的神经改善与长期 GFO 一致。既未出现早期也未出现延迟神经改善的患者仍能实现长期 GFO,但尚未研究这种结局的预测因素。
这项单中心回顾性研究纳入了 307 例接受机械取栓治疗的前循环 AIS 患者。收集并分析了多种临床、生化、影像学和治疗相关变量。第 7 天的 DNI 定义为 NIHSS 评分至少降低 10 分或 NIHSS 评分<2 分。第 90 天的 GFO 定义为改良 Rankin 量表(mRS)评分≤2 分。我们比较了有和无 DNI 患者的特征,特别关注尽管无 DNI 但仍实现 90-GFO 的患者。然后进行多变量分析,以确定无 DNI 患者 90 天 GFO 的独立预测因素。
307 例患者中有 150 例(48.7%)出现 DNI,显著增加了 90 天 GFO 的几率(比值比[OR]:13.99;p<0.001)。在无 DNI 的患者中,41.4%实现了 90 天 GFO。年龄较小(OR:0.96;95%置信区间[CI]:0.93-0.99;p=0.008)、基线 NIHSS 评分较低(OR:0.80;95% CI:0.73-0.89;p<0.001)、接受静脉溶栓治疗(OR:3.06;95% CI:1.25-7.49;p=0.014)、病因不明(OR:0.40;95% CI:0.16-0.998;p=0.050)、无肺炎(OR:0.08;95% CI:0.02-0.31;p<0.001)和入院时血红蛋白浓度较高(OR:1.31;95% CI:1.04-1.69;p=0.024)是该亚组 90 天 GFO 的预测因素。
接受机械取栓治疗的前循环 AIS 患者中近一半出现 DNI,这是 90 天 GFO 的良好预测因素。此外,40%无 DNI 的患者实现了 90 天 GFO,这可以通过年龄较小、基线 NIHSS 评分较低、接受静脉溶栓治疗、入院时血红蛋白浓度较高、病因不明和无肺炎独立预测。